TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
16 hedge funds and large institutions have $1.51M invested in Titan Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
5
Closed
6
Calls
$257K
Puts
$411K
Net Calls
-$154K
Net Calls Change
+$104K
Top Buyers
1 |
Morgan Stanley
New York
|
+$413K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$342K |
3 |
Citadel Advisors
Miami,
Florida
|
+$129K |
4 |
VF
Virtu Financial
New York
|
+$87K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$45.7K |
Top Sellers
1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$119K |
2 |
![]()
Group One Trading
Chicago,
Illinois
|
-$114K |
3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$69K |
4 |
Millennium Management
New York
|
-$50K |
5 |
UBS Group
Zurich,
Switzerland
|
-$40.3K |